NRx Pharmaceuticals, Inc. (NRXP) Tops Q2 EPS by 1c,

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Qualcomm investor day to detail data center plans Wednesday
• Carnival shares drop despite earnings beat on weak guidance